Exxonmobil Investment Management Inc. TX lowered its position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 17.9% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 138,050 shares of the pharmacy operator’s stock after selling 30,007 shares during the quarter. Exxonmobil Investment Management Inc. TX’s holdings in Walgreens Boots Alliance were worth $10,025,000 as of its most recent filing with the SEC.

Several other large investors have also recently modified their holdings of the company. Commonwealth Bank of Australia lifted its position in Walgreens Boots Alliance by 139.5% during the 2nd quarter. Commonwealth Bank of Australia now owns 46,167 shares of the pharmacy operator’s stock worth $3,614,000 after acquiring an additional 26,893 shares in the last quarter. Andra AP fonden lifted its position in Walgreens Boots Alliance by 6.9% during the 3rd quarter. Andra AP fonden now owns 62,300 shares of the pharmacy operator’s stock worth $4,811,000 after acquiring an additional 4,000 shares in the last quarter. Schwab Charles Investment Management Inc. lifted its position in Walgreens Boots Alliance by 5.4% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 3,019,739 shares of the pharmacy operator’s stock worth $236,476,000 after acquiring an additional 154,995 shares in the last quarter. Birinyi Associates Inc. lifted its position in Walgreens Boots Alliance by 9.0% during the 2nd quarter. Birinyi Associates Inc. now owns 9,100 shares of the pharmacy operator’s stock worth $713,000 after acquiring an additional 750 shares in the last quarter. Finally, Legal & General Group Plc lifted its position in Walgreens Boots Alliance by 5.2% during the 2nd quarter. Legal & General Group Plc now owns 4,550,856 shares of the pharmacy operator’s stock worth $356,368,000 after acquiring an additional 223,186 shares in the last quarter. Institutional investors and hedge funds own 61.20% of the company’s stock.

Walgreens Boots Alliance Inc (WBA) opened at $76.03 on Wednesday. Walgreens Boots Alliance Inc has a 52-week low of $63.82 and a 52-week high of $88.00. The stock has a market capitalization of $75,300.00, a P/E ratio of 21.00, a price-to-earnings-growth ratio of 1.29 and a beta of 1.22. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.96 and a quick ratio of 0.47.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.27 by $0.01. Walgreens Boots Alliance had a return on equity of 19.15% and a net margin of 3.19%. The company had revenue of $30.74 billion for the quarter, compared to analyst estimates of $30.39 billion. During the same period in the prior year, the company posted $1.10 EPS. Walgreens Boots Alliance’s quarterly revenue was up 7.9% on a year-over-year basis. equities research analysts anticipate that Walgreens Boots Alliance Inc will post 5.7 earnings per share for the current year.

Walgreens Boots Alliance announced that its board has initiated a stock buyback plan on Wednesday, October 25th that permits the company to buyback $1.00 billion in outstanding shares. This buyback authorization permits the pharmacy operator to purchase shares of its stock through open market purchases. Shares buyback plans are often an indication that the company’s management believes its stock is undervalued.

Several research firms recently commented on WBA. Needham & Company LLC reissued a “buy” rating and set a $88.00 price target (up from $86.00) on shares of Walgreens Boots Alliance in a research report on Wednesday, January 10th. BidaskClub raised Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research report on Wednesday, January 10th. Loop Capital set a $90.00 price target on Walgreens Boots Alliance and gave the stock a “buy” rating in a research report on Thursday, October 26th. Robert W. Baird reissued an “outperform” rating and set a $80.00 price target (down from $90.00) on shares of Walgreens Boots Alliance in a research report on Thursday, October 19th. They noted that the move was a valuation call. Finally, Royal Bank of Canada began coverage on Walgreens Boots Alliance in a research report on Tuesday, September 19th. They set an “outperform” rating and a $96.00 price target on the stock. Nine investment analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the company’s stock. Walgreens Boots Alliance currently has a consensus rating of “Buy” and an average target price of $86.20.

In other news, Director John Anthony Lederer purchased 20,000 shares of the company’s stock in a transaction that occurred on Thursday, October 26th. The shares were acquired at an average cost of $67.00 per share, with a total value of $1,340,000.00. Following the transaction, the director now owns 50,000 shares in the company, valued at approximately $3,350,000. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction that occurred on Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total value of $184,324.32. Following the sale, the director now directly owns 16,415 shares in the company, valued at $1,105,878.55. The disclosure for this sale can be found here. Corporate insiders own 14.80% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Exxonmobil Investment Management Inc. TX Decreases Stake in Walgreens Boots Alliance Inc (WBA)” was first posted by Watch List News and is owned by of Watch List News. If you are accessing this article on another publication, it was illegally stolen and republished in violation of US & international trademark & copyright law. The legal version of this article can be read at https://www.watchlistnews.com/exxonmobil-investment-management-inc-tx-decreases-stake-in-walgreens-boots-alliance-inc-wba/1810313.html.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with Analyst Ratings Network's FREE daily email newsletter.